Use of recombinant bone morphogenetic protein is associated with reduced risk of reoperation after spine fusion for adult spinal deformity

Justin C. Paul, Baron S. Lonner, Shaleen Vira, Ian David Kaye, Thomas J. Errico

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Use of recombinant bone morphogenetic protein is associated with reduced risk of reoperation after spine fusion for adult spinal deformity'. Together they form a unique fingerprint.

Medicine & Life Sciences